Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Pancreatic Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 2Colonic Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Neutropenia 1Glioblastoma 1Gastrointestinal Neoplasms 1Diarrhea 1Colon Cancer Liver Metastasis 1Carcinoma 1

Interventions

Loperamide 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Diarrhea × Irinotecan × Clear all
NCT01523431 2017-03-30

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase 2/3 Completed
583 enrolled
Gastrointestinal

Diarrhea, Neutropenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡